Despite extensive research and various interventions designed to improve adherence to treatment of chronic conditions, medication non-adherence persists among patients with diabetes, including those prescribed insulin, leading to poor health outcomes [1, 23–26]. This evidence concerns the gene INS and diabetes mellitus.